Der bisherige mittelfristige Trend von Verenium wird nach oben durchbrochen werden. Die Prognose für Verenium für den 16. April ist 3,35 Euro.
| 1,667 Euro | -0,001 -0,06 % | ||
| WKN: A0X9PR ISIN: US92340P2092 Ticker-Symbol: DVG1 | Frankfurt | 21.05.13 | 16:12 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | |
|---|---|---|
| 10.05. | Verenium's CEO Discusses Q1 2013 Results - Earnings Call Transcript | |
Mehr lesen zu: Verenium's CEO Discusses Q1 2013 Results - Earnings Call Transcript | ||
| 09.05. | VERENIUM CORP - 8-K, Current Report | |
Mehr lesen zu: VERENIUM CORP - 8-K, Current Report | ||
| 09.05. | Verenium Reports Financial Results For The First Quarter Ended March 31, 2013 | |
| SAN DIEGO, May 9, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes,... Mehr lesen zu: Verenium Reports Financial Results For The First Quarter Ended March 31, 2013 | ||
| 02.05. | Verenium Corporation to Announce First Quarter 2013 Financial Results | |
| SAN DIEGO, May 2, 2013 /PRNewswire/ --Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance... Mehr lesen zu: Verenium Corporation to Announce First Quarter 2013 Financial Results | ||
| 28.03. | Verenium's CEO Discusses Q4 2012 Results - Earnings Call Transcript | |
Mehr lesen zu: Verenium's CEO Discusses Q4 2012 Results - Earnings Call Transcript |
